Pelikan closes $25M for handheld diagnostics
Pelikan Technologies, maker of medical devices for diagnosing and monitoring diabetes, just brought in $25 million from undiclosed investors, reports VentureWire. Based in Palo Alto, Calif., the company spun out of Agilent Technologies in 2001 with the launch of its Pelikan Sun line, an electronic lancing device used to test blood sugar.
This round of capital brings its total raised to $145 million (it last raised $89 million at the end of 2007). Past investors (that… Continue Reading
Pelikan scoops up $12.5M for diabetes diagnostics
Pelikan Technologies, maker of diagnostic and health-monitoring devices that can be used by regular people, nabbed a $12.5 million tranche of an expected $25 million seventh round of funding, according to VentureWire. Its flagship product, the handheld diabetes tester Pelikan Sun, is already on the market and is even being targeted for children.
The Palo Alto, Calif.-based company has raised $145 million to date. Its most recent round amounted to $69 million last December. Contributors to… Continue Reading
Life-science briefing: Thursday, March 27, 2008
TODAY’S HEADLINES:
Breathe Tech raises $15M for respiratory disease (release)
Protein-drug maker Pieris takes in €25M (release)
Apthera takes in $2.1M toward cancer vaccine (VentureWire)
Breathe Tech raises $15M for respiratory disease – Breathe Technologies, a Fremont, Calif., medical device maker, raised $15 million in a second round of funding. Investors included Kleiner Perkins Caufield & Byers, Synergy Partners International, Delphi Ventures and Life Science Angels.
Breathe is developing “compact” and “lightweight” respiratory systems for the hospital and home markets, and… Continue Reading
Pelikan Tech to push “finger friendly” diabetes testing
One of the constant but unavoidable challenges in trying to control diabetes is the frequent need to test blood-sugar levels by sticking a needle into a fingertip — a step that tells diabetics when they need a snack (to raise blood glucose) or a shot of insulin (to lower it). “Lancing” fingers several times a day can render the tips so tender that it restricts ordinary activity — playing the piano, for instance — for… Continue Reading
Life sciences briefing: Wednesday, Aug. 29, 2007
(UPDATED at 3:10pm PT: See below.)
Featured companies: Agendia, EndoGastric Solutions, FlowCo, Gentris, MedManage Systems, ParagonDx, Presidio Pharmaceuticals, Xoova
Presidio Pharma raises $26M for viral treatments — San Francisco’s Presidio Pharmaceuticals, a biotech developing new antiviral drugs, raised $26 million in a second funding round. Investors included Panorama Capital, Baker Brothers Investments, Bay City Capital, Ventures West Capital, Nexus Medical Partners, Sagamore Bioventures, George Rathmann Fund and Peninsula Overview Partners.
Presidio’s lead drug candidates take aim at HIV, hepatitis… Continue Reading
Coapt Systems, maker of aesthetic surgery implants, raises $22.6M more
Coapt Systems, a Palo Alto, Ca. maker of bioabsorbable implants for use in aesthetic surgery, has raised $22.6 million in a fifth funding.
The round, led by Global Life Science Ventures and Easton Capital, included existing investors Alta Partners, Asset Management Company, Canaan Partners, Boston Millennia Partners, and Foundation Medical Partners.
Coapt Systems, founded in 2000, has developed implantable soft tissue fixation devices for use in facial plastic surgery. The company’s pipeline also includes a hand… Continue Reading